Pharma

Your Article Summary

See Latest Articles

USPTO issues a Notice of Allowance for MMDI's BetaWire Guidewire Patent
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08

Minnesota Medical Development, Inc. (MMDI) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company’s BetaWire guidewire technology. The BetaWire is a super-torque interventional guidewire manufactured from a Beta Titanium alloy.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09

Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09

Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09

See All of Regulatory Issues